Value of MRI and MRS fat measurements to complement conventional screening methods for childhood obesity

Journal of Magnetic Resonance Imaging

Volumn 42, Issue 5, 2015, Pages 1214-1222

  Lange, Thomas ^a,b   Buechert, Martin ^a   Baumstark, Manfred W ^a   Deibert, Peter ^a   Gerner, Sarah ^a   Rydén, Henric ^a   Seufert, Jochen ^a   Korsten Reck, Ulrike ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

abdominal obesity; childhood obesity; liver; magnetic resonance; metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; THYROTROPIN; TRIACYLGLYCEROL;

ABDOMINAL GIRTH; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY FAT DISTRIBUTION; BODY MASS; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FAT CONTENT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INTRAABDOMINAL FAT; LIMIT OF QUANTITATION; MALE; METABOLIC PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; PRIORITY JOURNAL; SCREENING TEST; SKINFOLD THICKNESS; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ABDOMINAL FAT; MIDDLE AGED; PATHOLOGY; PEDIATRIC OBESITY;

ABDOMINAL FAT; ADOLESCENT; BODY MASS INDEX; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PEDIATRIC OBESITY; PILOT PROJECTS;

EID: 84945478728     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24919     Document Type: Article

References (55)

1. Iacobellis A, Marcellini M, Andriulli A, et al., Noninvasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J Gastroenterol WJG 2006; 12: 7821-7825.
2. Angulo P., Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
3. Brunt EM., Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis 2009; 13: 533-544.
4. Manco M., Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. J Am Coll Nutr 2011; 30: 295-303.
5. Jacome-Sosa MM, Parks EJ., Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Curr Opin Lipidol 2014; 25: 213-220.
6. Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ., Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 2014; 146: 726-735.
7. Than NN, Newsome PN., A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015; 239: 192-202.
8. Nobili V, Alisi A, Raponi M., Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol WJG 2009; 15: 6017-6022.
9. Roden M., Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006; 2: 335-348.
10. Utzschneider KM, Kahn SE., Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006; 91: 4753-4761.
11. Larson-Meyer DE, Newcomer BR, Ravussin E, et al., Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children. Diabetologia 2011; 54: 869-875.
12. Mann JP, Goonetilleke R, McKiernan P., Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Arch Dis Child 2015 [Epub ahead of print].
13. Pacifico L, Martino MD Catalano C, et al., T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. World J Gastroenterol WJG 2011; 17: 3012-3019.
14. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A., MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr Oslo Nor 1992 2007; 96: 542-547.
15. D'Adamo E, Cali AMG, Weiss R, et al., Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010; 33: 1817-1822.
16. Springer F, Ehehalt S, Sommer J, et al., Assessment of relevant hepatic steatosis in obese adolescents by rapid fat-selective GRE imaging with spatial-spectral excitation: a quantitative comparison with spectroscopic findings. Eur Radiol 2011; 21: 816-822.
17. Springer F, Ehehalt S, Sommer J, et al., Predicting volumes of metabolically important whole-body adipose tissue compartments in overweight and obese adolescents by different MRI approaches and anthropometry. Eur J Radiol 2012; 81: 1488-1494.
18. Raschpichler M, Sorge I, Hirsch W, et al., Evaluating childhood obesity: magnetic resonance-based quantification of abdominal adipose tissue and liver fat in children. RöFo 2012; 184: 324-332.
19. Linder K, Springer F, Machann J, et al., Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity 2014; 22: 1325-1331.
20. Pozzato C, Verduci E, Scaglioni S, et al., Liver fat change in obese children after a 1-year nutrition-behavior intervention. J Pediatr Gastroenterol Nutr 2010; 51: 331-335.
21. Radetti G, Kleon W, Stuefer J, Pittschieler K., Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Acta Paediatr Oslo Nor 1992 2006; 95: 833-837.
22. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB., Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 2014; 12: 765-773.
23. Ma J., Dixon techniques for water and fat imaging. J Magn Reson Imaging JMRI 2008; 28: 543-558.
24. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB., Multiecho water-fat separation and simultaneous R2∗ estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008; 60: 1122-1134.
25. Machann J, Thamer C, Schnoedt B, et al., Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging JMRI 2005; 21: 455-462.
26. Kim H, Taksali SE, Dufour S, et al., Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med 2008; 59: 521-527.
27. Livingstone RS, Begovatz P, Kahl S, et al., Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with 1H MRS. Magn Reson Mater Phys Biol Med 2013; 27: 397-405.
28. 1H MR spectroscopy, 3-point Dixon, and multi-echo gradient echo for measuring hepatic fat fraction. Magn Reson Med Sci 2011; 10: 41-48.
29. Artz NS, Haufe WM, Hooker CA, et al., Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects: 1.5T vs. 3T liver fat quantification. J Magn Reson Imaging 2015 [Epub ahead of print].
30. Yokoo T, Shiehmorteza M, Hamilton G, et al., Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011; 258: 749-759.
31. Qayyum A., MR spectroscopy of the liver: principles and clinical applications. Radiogr Rev 2009; 29: 1653-1664.
32. Cho SG, Kim MY, Kim HJ, et al., Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001; 221: 740-746.
33. Hamilton G, Yokoo T, Bydder M, et al., In vivo characterization of the liver fat H-1 MR spectrum. NMR Biomed 2011; 24: 784-790.
34. Tyszka JM, Silverman JM., Navigated single-voxel proton spectroscopy of the human liver. Magn Reson Med 1998; 39: 1-5.
35. Germuska M, Tunariu N, Leach MO, Xu J, Payne GS., An evaluation of motion compensation strategies and repeatability for abdominal (1)H MR spectroscopy measurements in volunteer studies and clinical trials. NMR Biomed 2012; 25: 859-865.
36. Korsten-Reck U, Kromeyer-Hauschild K, Wolfarth B, Dickhuth H-H, Berg A., Freiburg Intervention Trial for Obese Children (FITOC): results of a clinical observation study. Int J Obes 2005; 29: 356-361.
37. Kurth B-M, Schaffrath Rosario A,. [The prevalence of overweight and obese children and adolescents living in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)] (in German). Bund Gesund Gesund 2007; 50: 736-743.
38. Cole TJ, Green PJ., Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992; 11: 1305-1319.
39. Fields DA, Goran MI, McCrory MA., Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr 2002; 75: 453-467.
40. Berg A, Korsten-Reck U., Strategien zur Verbesserung des Aktivitäts-und Ernährungsverhaltens bei Kindern und Jugendlichen. Lipidreport 1995; 4: 15-22.
41. Thesen S, Heid O, Mueller E, Schad LR., Prospective acquisition correction for head motion with image-based tracking for real-time fMRI. Magn Reson Med 2000; 44: 457-465.
42. Hernando D, Kellman P, Haldar JP, Liang ZP., Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn Reson Med 2010; 63: 79-90.
43. Kass M, Witkin A, Terzopoulos D., Snakes-active contour models. Int J Comput Vis 1987; 1: 321-331.
44. Hu HH, Nayak KS., Quantification of absolute fat mass using an adipose tissue reference signal model. J Magn Reson Imaging 2008; 28: 1483-1491.
45. Ludwig UA, Klausmann F, Baumann S, et al., Whole-body MRI-based fat quantification: a comparison to air displacement plethysmography. J Magn Reson Imaging 2014; 40: 1437-1444.
46. Provencher SW., Estimation of metabolite concentrations from localized in-vivo proton NMR-spectra. Magn Reson Med 1993; 30: 672-679.
47. Hamilton G, Middleton MS, Bydder M, et al., Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009; 30: 145-152.
48. Machann J, Thamer C, Schnoedt B, et al., Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 2006; 55: 913-917.
49. Ye Q, Danzer CF, Fuchs A, Wolfrum C, Rudin M., Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy. Magn Reson Mater Phys Biol Med 2012; 25: 381-389.
50. Ye Q, Danzer CF, Fuchs A, Vats D, Wolfrum C, Rudin M., Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice: progression of hepatic lipids in ob/ob mice and ob/+ controls. NMR Biomed 2013; 26: 1079-1088.
51. Bedossa P, Carrat F., Liver biopsy: the best, not the gold standard. J Hepatol 2009; 50: 1-3.
52. Manco M, Alisi A, Real J-MF, et al., Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. J Hepatol 2011; 55: 647-653.
53. Després J-P, Lemieux I., Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
54. Coutinho T, Goel K, Corrêa de Sá; D, et al., Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity." J Am Coll Cardiol 2013; 61: 553-560.
55. Vissers D, Hens W, Taeymans J, Baeyens J-P, Poortmans J, Van Gaal L., The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PloS One 2013; 8: e56415.